Philip Tsai's most recent trade in Immunome Inc was a trade of 10,000 Common Stock done at an average price of $20.5 . Disclosure was reported to the exchange on Dec. 19, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Immunome Inc | Philip Tsai | Chief Technical Officer | Purchase of securities on an exchange or from another person at price $ 20.49 per share. | 19 Dec 2025 | 10,000 | 43,300 | - | 20.5 | 204,900 | Common Stock |
| Immunome Inc | Philip Tsai | Chief Technical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jul 2025 | 190,000 | 190,000 | - | - | Employee Stock Option (right to buy) | |
| Immunome Inc | Philip Tsai | Chief Technology Officer | Purchase of securities on an exchange or from another person at price $ 8.42 per share. | 24 Mar 2025 | 12,300 | 33,300 | - | 8.4 | 103,566 | Common Stock |
| Immunome Inc | Philip Tsai | Chief Technology Officer | 21 Nov 2024 | 21,000 | 21,000 | - | 9.4 | 198,030 | Common Stock | |
| Immunome Inc | Philip Tsai | Chief Technology Officer | 17 Jun 2024 | 250,000 | 250,000 | - | - | Stock option (right to buy) |